Published July 15, 2025 | Version v1
Other Open

Is dapagliflozin indicated for the treatment of IgA glomerulopathy?

Authors/Creators

  • 1. Tripdatabase

Description

Dapagliflozin has shown potential in reducing kidney disease progression in IgA nephropathy according to recent studies, though further investigation is warranted for long-term safety and efficacy.

Files

14a6192d-c18a-49e7-a810-bc3e4975d1ed.pdf

Files (18.5 kB)

Name Size
md5:7aacd2d7dcf142f28d1efa8ff54f8a16
18.5 kB Preview Download

Additional details